Boston Scientific announces upcoming investor conference schedule

Rhea-AI Summary

Boston Scientific (NYSE: BSX) will present at two investor conferences in late 2025. On November 18, 2025 at ~8:00 a.m. ET Kenneth Stein, M.D., and Lauren Tengler will join a 30-minute Q&A at Wolfe Research's 7th Annual Healthcare Conference. On December 2, 2025 at ~9:00 a.m. ET Joe Fitzgerald, Janar Sathananthan, M.D., and Lauren Tengler will join a 40-minute Q&A at Citi's 2025 Global Healthcare Conference. Live webcasts and replays for both events will be accessible at the company investor site, with replays available about one hour after each event ends.

MARLBOROUGH, Mass., Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

On November 18, 2025, Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at Wolfe Research's 7^th Annual Healthcare Conference. The session will begin at approximately 8:00 a.m. ET.

On December 2, 2025, Joe Fitzgerald, executive vice president and group president, Cardiology, Janar Sathananthan, M.D., chief medical officer, Interventional Cardiology Therapies, and Lauren Tengler, vice president, Investor Relations will participate in a 40-minute question-and-answer session with the host analyst at Citi's 2025 Global Healthcare Conference. The session will begin at approximately 9:00 a.m. ET.

A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn. 

CONTACTS:
Emily Anderson
Media Relations
+1 (617) 515-2000
Emily.Anderson2@bsci.com

Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-upcoming-investor-conference-schedule-302600845.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific (BSX) present at Wolfe Research's 7th Annual Healthcare Conference?

Boston Scientific will present on November 18, 2025 at approximately 8:00 a.m. ET in a 30-minute Q&A session.

Who will appear for Boston Scientific (BSX) at the Wolfe Research event on November 18, 2025?

Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lauren Tengler, vice president, Investor Relations.

When and who will represent Boston Scientific (BSX) at Citi's 2025 Global Healthcare Conference?

Boston Scientific will present on December 2, 2025 at approximately 9:00 a.m. ET with Joe Fitzgerald, Janar Sathananthan, M.D., and Lauren Tengler in a 40-minute Q&A.

Where can investors watch the Boston Scientific (BSX) webcasts and replays for the November 18 and December 2, 2025 presentations?

Live webcasts and replays will be available at https://investors.bostonscientific.com, with replays posted about one hour after each event concludes.

How long are the Boston Scientific (BSX) sessions at the November 18 and December 2, 2025 conferences?

The Wolfe Research session is 30 minutes and the Citi session is 40 minutes.